Clin2
NCT07765160Possibly a fitNot yet recruiting

Study of IBI3040 for weight loss in overweight and obese adults

Healthy ParticipantsOverweight or Obese Participants

Part of Hormones & metabolism clinical trials.

This study tests an investigational drug called IBI3040 in healthy volunteers and in people who are overweight or obese. It aims to see if the drug is safe and how it affects body weight.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
96 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • Be between 18 and 65 years old
  • Have a body mass index (BMI) between 24 and 40 for the multiple-dose part
  • Agree to use effective contraception and not donate sperm or eggs during the study
  • Be generally healthy and able to comply with study procedures
  • Not have diabetes, pancreatitis, thyroid conditions, or certain other medical issues
  • Not have taken weight-loss drugs or certain other medications recently

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07793019Not yet recruiting· Phase 1
Weight loss and safety study in overweight adults

This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.

Beijing, Beijing Municipality
NCT07160400Recruiting· Phase 1
Study of IBI3032 for healthy participants and those with overweight or obesity

This trial tests a new medication called IBI3032 in healthy people and those with overweight or obesity. It aims to see if the drug is safe and how the body processes it.

Shanghai, Shanghai Municipality
NCT07662122Recruiting· Phase 2
Testing a new weight loss medication in adults with obesity or overweight

This trial tests an investigational drug called BI 3034701 to see if it helps people lose weight. It is for adults who are obese or overweight with at least one weight-related health problem.

Birmingham, Alabama
NCT07754474Not yet recruiting· Phase 1
Testing a new medicine for overweight or obesity

This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.

Mannheim
NCT07487376Recruiting· Phase 1
A single-dose study of IBIO-600 in healthy overweight or obese adults

This trial tests a single dose of an experimental treatment called IBIO-600 to see if it's safe and how it works in overweight or obese adults. It's for people who are generally healthy and have a stable weight, without diabetes.

Bayswater, Victoria
NCT07291232Recruiting· Phase 1
Study of an injected drug for adults with obesity

This study tests an injected medication called ABBV-295 for adults with obesity. The goal is to see how safe it is and how the body processes it. You may join if you have a BMI between 30 and 45 and are generally healthy, and you haven't been on other weight loss treatments recently.

Anaheim, California

Hear when a new Healthy Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.